Preliminary Efficacy Report of a Novel Thrombolytic Agent for Acute Ischaemic Stroke within a 5-Hour Window

被引：0
|
作者：
A-Ching Chao
Michael Mu-Huo Teng
Chih-Ping Chung
Hsing-Yu Weng
Yen-Yu Chen
Fu-Yi Yang
Lee-Min Wang
Han-Hwa Hu
机构：
[1] Kaohsiung Medical University and Hospital,Department of Neurology
[2] Taipei Veterans General Hospital,Department of Radiology
[3] Taipei Veterans General Hospital,Department of Neurology, Neurological Institute
[4] Taipei Veterans General Hospital,Department of Emergency Room
来源：
CNS Drugs | 2007年 / 21卷
关键词：
Acute Ischaemic Stroke; Severe Acute Respiratory Syndrome; Alteplase; Barthel Index; Glasgow Outcome Scale;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Adopting thrombolytic therapy with tissue plasminogen activator (tPA) in clinical practice presents many challenges. One major factor is the restrictive time window of 0–3 hours after symptom onset, for the commencement of treatment.
引用
收藏
页码：937 / 946
页数：9
相关论文
共 25 条
  • [21] Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4<middle dot>5 h after stroke onset (PROST-2): a phase 3, open-label non-inferiority, randomised controlled trial
    Li, Shuya
    Gu, Hong-Qiu
    Feng, Baoyu
    Li, Hao
    Wang, Xuechun
    Dong, Qiang
    Fan, Dongsheng
    Xu, Yun
    Zhu, Suiqiang
    Dai, Hongguo
    Wei, Yan
    Wang, Ziran
    Lu, Guozhi
    Ma, Yutong
    Li, Zixiao
    Wang, Yilong
    Meng, Xia
    Zhao, Xingquan
    Liu, Liping
    Wang, Yongjun
    LANCET NEUROLOGY, 2025, 24 (01): : 33 - 41
  • [22] Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischaemic stroke patients (SEANCON)
    Blacker, David J.
    Hankey, Graeme J.
    Thomas, Meghan
    Phillips, Tim
    Bailey, Paul
    Donnan, Geoffrey
    Saver, Jeffrey L.
    South, Samantha
    Knuckey, Neville
    Meloni, Bruno
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (02) : 46 - 46
  • [23] DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4-5 h if symptom onset (PRE-FLAIR): a multicentre observational study
    Thomalla, Goetz
    Cheng, Bastian
    Ebinger, Martin
    Hao, Qing
    Tourdias, Thomas
    Wu, Ona
    Kim, Jong S.
    Breuer, Lorenz
    Singer, Oliver C.
    Warach, Steven
    Christensen, Soren
    Treszl, Andras
    Forkert, Nils D.
    Galinovic, Ivana
    Rosenkranz, Michael
    Engelhorn, Tobias
    Koehrmann, Martin
    Endres, Matthias
    Kang, Dong-Wha
    Dousset, Vincent
    Sorensen, A. Gregory
    Liebeskind, David S.
    Fiebach, Jochen B.
    Fiehler, Jens
    Gerloff, Christian
    LANCET NEUROLOGY, 2011, 10 (11): : 978 - 986
  • [24] The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4•5 h of onset of symptoms
    Amaro, Sergio
    Canovas, David
    Castellanos, Mar
    Gallego, Jaime
    Marti-Fabregas, Joan
    Segura, Tomas
    Chamorro, Angel
    INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (04) : 325 - 328
  • [25] COMPARISON OF EFFICACY AND SAFETY OF 5-DAY AND 10-DAY SCHEDULES OF SGI-110, A NOVEL SUBCUTANEOUS (SC) HYPOMETHYLATING AGENT (HMA), IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)
    Roboz, G. J.
    Ravandi, F.
    Kropf, P.
    Yee, K.
    O'Connell, C.
    Griffiths, E.
    Stock, W.
    Garcia-Manero, G.
    Jabbour, E.
    Daver, N.
    Pemmaraju, N.
    Issa, J.
    Walsh, K.
    Rizzieri, D.
    Lunin, S.
    Naim, S.
    Hao, Y.
    Azab, M.
    Kantarjian, H.
    ANNALS OF ONCOLOGY, 2014, 25
123